Wordt geladen...
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study
The pangenotypic regimen of glecaprevir and pibrentasvir (G/P) is approved to treat adults with chronic hepatitis C virus (HCV) infection and has yielded high cure rates in adults in clinical trials. Approved treatment options for pediatrics may include ribavirin. A pangenotypic regimen for pediatri...
Bewaard in:
| Gepubliceerd in: | Hepatology |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7028097/ https://ncbi.nlm.nih.gov/pubmed/31254392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30840 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|